env Chimeric Virus Technology for Evaluating Human Immunodeficiency Virus Susceptibility to Entry Inhibitors

We describe the development of chimeric virus technology (CVT) for human immunodeficiency virus (HIV) type 1 (HIV-1) env genes gp120, gp41, and gp160 for evaluation of the susceptibilities of HIV to entry inhibitors. This env CVT allows the recombination of env sequences derived from different strai...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	Fikkert, Valery, Cherepanov, Peter, Van Laethem, Kristel, Hantson, Anke, Van Remoortel, Barbara, Pannecouque, Christophe, De Clercq, Erik, Debyser, Zeger, Vandamme, Anne-Mieke, Witvrouw, Myriam
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 2002
Schlagworte:	Antiviral Agents
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC132780/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12435701/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.12.3954-3962.2002
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!